TABLE 3.
Abdominal Obesity† PR (95% CI) |
High Triglycerides‡ PR (95% CI) |
Low HDL§ PR (95% CI) |
High Blood Pressure‖ PR (95% CI) |
High Fasting Glucose¶ PR (95% CI) |
Metabolic Syndrome# PR (95% CI) |
|
---|---|---|---|---|---|---|
Solvents | 1.00 (0.85–1.16) | 1.00 (0.80–1.26) | 0.81 (0.66–1.00) | 1.32 (1.09–1.60) | 1.01 (0.82–1.26) | 0.95 (0.75–1.20) |
Metals | 1.00 (0.88–1.14) | 1.04 (0.86–1.27) | 1.06 (0.90–1.24) | 1.04 (0.86–1.27) | 0.99 (0.80–1.22) | 1.07 (0.88–1.31) |
Pesticides | 0.98 (0.82–1.16) | 1.03 (0.80–1.31) | 0.93 (0.74–1.18) | 1.02 (0.81–1.30) | 1.13 (0.92–1.39) | 1.09 (0.87–1.38) |
95% CI, 95% confidence interval.
Adjusted for confounders using the analytic weights.
Abdominal obesity was defined as a waist circumference ≥88 cm for women or ≥102 cm inches for men.
High triglycerides was defined as ≥150 mg/dL.
Low HDL was defined as <50 mg/dL for women or <40 mg/dL for men.
High blood pressure was defined as systolic blood pressure ≥130 mm Hg, diastolic blood pressure ≥85 mm Hg, or current use of medication to treat high blood pressure.
High fasting blood glucose was defined as ≥100 mg/dL or current use of medication to treat hyperglycemia.
Metabolic syndrome was defined using the AHA/NHBLI definition of meeting at least 3 of the 5 criteria (abdominal obesity, high triglycerides, low HDL, high blood pressure, or high fasting blood glucose).